Journal of Parkinsons Disease

Papers
(The median citation count of Journal of Parkinsons Disease is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention142
When Parkinson's disease interferes in a couple's life: A qualitative study112
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?85
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists70
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease68
A framework to standardize gait study protocols in Parkinson's disease66
Clinical Trial Highlights: Modulators of Mitochondrial Function62
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression58
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort56
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients56
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”56
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders50
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease48
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review48
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder48
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease47
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”47
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease46
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease44
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy43
No Higher Risk-Seeking Tendencies or Altered Self-Estimation in a Social Decision-Making Task in Patients with Parkinson’s Disease42
What medicines do people with Parkinson's disease want?41
The fixel GI Parkinson's research and integrated support model (PRISM)38
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease38
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease37
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease35
A possible pathway to freezing of gait in Parkinson's disease35
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis35
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative34
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?34
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease33
Are Preformed Fibrils a Model of Parkinson’s Disease?33
Nomogram for Early Prediction of Parkinson’s Disease Based on microRNA Profiles and Clinical Variables31
Twenty-five-year experience with apomorphine pump in Parkinson's disease: A real-life long-term retrospective tolerance study29
Deficient Interhemispheric Connectivity Underlies Movement Irregularities in Parkinson’s Disease29
Burden, Anxiety, and Depression Among Caregivers of Parkinson’s Disease Patients29
Mild cognitive impairment is not predictive of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson's disease29
Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks28
Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia27
Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease27
Mortality and causes of death in patients with Parkinson's disease in Taiwan27
Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease26
Metabolic connectivity of freezing in Parkinson's disease25
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy25
Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain25
Burden of tremor in Parkinson's disease: A survey study25
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease24
Feasibility and Proof-of-Concept of Delivering an Autonomous Music-Based Digital Walking Intervention to Persons with Parkinson’s Disease in a Naturalistic Setting24
The Role of Diet in Parkinson’s Disease24
Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice24
Surveying Global Availability of Parkinson’s Disease Treatment24
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies23
Modulation of Cerebellar Oscillations with Subthalamic Stimulation in Patients with Parkinson’s Disease23
Acknowledgment to Reviewers 202222
Recruitment for Remote Decentralized Studies in Parkinson’s Disease22
Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's disease22
A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults22
Do Impulse Control Disorders Impair Car Driving Performance in Patients with Parkinson’s Disease?22
Hidden Gems in Neurology: The Syndrome of Hemiparkinsonism-Hemiatrophy22
Atypical parkinsonian syndromes in French Guiana: Similarities and differences with Caribbean variants22
Effects of Low-Intensity Vestibular Noise Stimulation on Postural Instability in Patients with Parkinson’s Disease21
Motor Memory Consolidation Deficits in Parkinson’s Disease: A Systematic Review with Meta-Analysis20
Gait Declines Differentially in, and Improves Prediction of, People with Parkinson’s Disease Converting to a Freezing of Gait Phenotype20
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population20
Symmetric and Profound Monoaminergic Degeneration in Parkinson’s Disease with Premotor REM Sleep Behavior Disorder20
A glimpse of the end-of-life of people with Parkinson's disease and atypical parkinsonism: A descriptive analysis of electronic health records20
Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review19
Anxiety-related attentional characteristics and their relation to freezing of gait in people with Parkinson's: Cross-validation of the Adapted Gait Specific Attentional Profile (G-SAP)19
Enhancing Participant Engagement in Clinical Studies: Strategies Applied in the Personalized Parkinson Project19
Parkinson’s Pals: A Student-Led Program to Facilitate Intergenerational Connections and Promote Psychosocial Well-Being Among Persons with Parkinson’s Disease19
Incretin Mimetics Restore the ER-Mitochondrial Axis and Switch Cell Fate Towards Survival in LUHMES Dopaminergic-Like Neurons: Implications for Novel Therapeutic Strategies in Parkinson’s Disease19
Non-Pharmacological Interventions for People with Parkinson’s Disease: Are We Entering a New Era?19
Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay19
Structural-Functional Correlates of Response to Pedunculopontine Stimulation in a Randomized Clinical Trial for Axial Symptoms of Parkinson’s Disease19
Enhancing Trial Delivery in Parkinson’s Disease: Qualitative Insights from PD STAT18
Unveiling the neural network of freezing of gait in Parkinson's disease: A coordinate-based network study18
“Tip-of-the-Tongue” Phenomenon in Parkinson’s Disease: A Hidden Gem18
Enhancing the diagnostic potential of electroretinography in Parkinson's disease: A review of protocol and cohort criteria18
Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life18
Reactive astrocyte-related pathogenic genes in Parkinson's disease: A multi-omics Mendelian randomization study18
The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s Disease18
Specialized Allied Health Care for Parkinson’s Disease: State of the Art and Future Directions18
Utility of a newly created questionnaire on subtle motor symptoms in high-risk subjects with Parkinson's disease18
Evaluating the Psychometric Properties of the Psychological Capital Questionnaire (PCQ) in Patients with Parkinson’s Disease18
Integrating virtual reality into multidisciplinary care for Parkinson's disease: A narrative review18
Tackling Parkinson’s Disease as a Global Challenge17
Buspirone regulates cortico-striatal gamma oscillations to ameliorate dyskinesia17
A Practical Guide to the Evaluation of Compensation Strategies for Gait Impairment in Parkinson’s Disease17
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model17
Feasibility and acceptability of PDConnect, a multi-component intervention to support physical activity in people with Parkinson's disease: A mixed methods study17
Sex-specific progression of Parkinson's disease: A longitudinal mixed-models analysis17
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?17
Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders16
Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity16
Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson’s Disease16
Neurodegeneration of the Globus Pallidus Internus as a Neural Correlate to Dopa-Response in Freezing of Gait16
Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson’s Disease and Other Synucleinopathies16
Remote Delivery of Allied Health Therapies in Parkinson’s Disease16
Discontinuation or acute unplanned cessation of oral dopaminergic medications in persons with Parkinson's disease: A practice review16
Gender Distribution in Deep Brain Stimulation for Parkinson’s Disease: The Effect of Awake versus Asleep Surgery16
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson’s Disease16
Unmet needs in the pharmacological management of motor symptoms in Parkinson's disease16
Trichloroethylene: An Invisible Cause of Parkinson’s Disease?15
Natural Health Products for Symptomatic Relief of Parkinson’s Disease: Prevalence, Interest, and Awareness15
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease15
40-Year Incidence of Early-Onset Parkinson’s Disease in Southeast Minnesota15
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease15
Echocardiographic insights into cardiovascular autonomic dysfunction in Parkinson's disease15
Kinematic Effects of Combined Subthalamic and Dorsolateral Nigral Deep Brain Stimulation in Parkinson’s Disease15
Designing the First Trials for Parkinson’s Prevention15
Diffuse putaminal degeneration without iron deposition in multiple system atrophy15
Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson’s Disease as a Multi-System Process15
Reduced Thickness of the Retina in de novo Parkinson’s Disease Shows A Distinct Pattern, Different from Glaucoma15
Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients14
Can People with Parkinson’s Disease Self-Trigger Gait Initiation? A Comparison of Cueing Strategies14
Pediatric-onset PRKN disease: New insights into an understudied population14
Advice to People with Parkinson’s in My Clinic: Orthostatic Hypotension14
Fatigue in de novo Parkinson’s Disease: Expanding the Neuropsychiatric Triad?14
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson’s Disease14
Inflammasome Activation in Parkinson’s Disease14
Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation14
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation14
Spinal Cord Stimulation for Gait Disorders in Parkinson’s Disease14
Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms14
RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions14
Impaired Inhibitory Control During Walking in Parkinson’s Disease Patients: An EEG Study13
Assessing the Role of Locus Coeruleus Degeneration in Essential Tremor and Parkinson’s Disease with Sleep Disorders13
The potential of distributed diagnostics for the early detection of Parkinson's disease13
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease13
Risk of Neurodegeneration in Patients with Rapid Eye Movement Sleep Behavior Disorder13
Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: A Surgicogenomic Approach13
Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease13
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease13
New insights from a Malaysian real-world deep brain stimulation cohort13
The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson’s Disease13
Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study12
Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease12
Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson’s Disease Trials12
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson’s Disease12
Pain Fluctuations in Parkinson’s Disease and Their Association with Motor and Non-Motor Fluctuations12
Letter to the Editor: Is It Too Early to Underrate Genetics onto PD Pathogenesis? Reflections on History12
Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group12
Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies12
The Role of Pathogens and Anti-Infective Agents in Parkinson’s Disease, from Etiology to Therapeutic Implications12
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease12
Acknowledgment to Reviewers 202312
Obstructive sleep apnea, periodic limb movements, and REM sleep without atonia are common in Parkinson's disease and correlate with motor symptom burden12
Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease12
The impact of diet on Parkinson's disease risk: A data-driven analysis in a large Italian case-control population11
Hypomimia May Influence the Facial Emotion Recognition Ability in Patients with Parkinson’s Disease11
Novel insights into relationships between metabolic covariance patterns of FDG-PET data and clinical status in Parkinson's disease using partial least squares correlation analysis11
Personality Changes After Subthalamic Nucleus Stimulation in Parkinson’s Disease11
Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson’s Disease with Cognitive Impairment: A Proof-of-Concept Study11
Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle11
Worsening of Parkinson’s Disease After Termination of COVID-19 Quarantine Cannot Be Reversed Despite Resumption of Physiotherapy11
Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease11
PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy10
Preparing for Parkinson’s disease prevention trials: Current progress and future directions10
Machine Learning-Based Classification of Parkinson’s Disease Patients Using Speech Biomarkers10
Screening Tools for Sarcopenia in Mild to Moderate Parkinson’s Disease: Assessing the Accuracy of SARC-F and Calf Circumference10
Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial10
Concordance between imaging and clinical based STN-DBS programming improves motor outcomes of directional stimulation in Parkinson's disease10
Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk10
How Information Affects Patients with Parkinson’s Disease: A Scoping Review of the Literature10
Relating movement behaviours and non-motor characteristics in people with Parkinson's disease: A compositional data analysis approach10
Disease Progression of Data-Driven Subtypes of Parkinson’s Disease: 5-Year Longitudinal Study from the Early Parkinson’s Disease Longitudinal Singapore (PALS) Cohort10
Dengue Virus Infection and Risk of Parkinson’s Disease: A Nationwide Longitudinal Study10
Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson’s Disease10
Development of a Screening Tool for Assessing Sexual Difficulties Among Patients with Parkinson’s Disease: The PD-SDS10
Oscillation-Specific Nodal Differences in Parkinson’s Disease Patients with Anxiety10
A PLAN to address the Parkinson pandemic10
Increasing trends in utilization of physical and occupational therapy services in early Parkinson's disease10
Evaluation and management of male sexual dysfunction in Parkinson's disease: A clinical road map10
Insights on Genetic and Environmental Factors in Parkinson’s Disease from a Regional Swedish Case-Control Cohort10
Retrograde Procedural Memory in Parkinson’s Disease: A Cross-Sectional, Case-Control Study10
Surface electromyographic profiles during gait initiation in people with Parkinson's disease: The effects of external sensory cueing9
Motor outcomes in unilateral, bilateral rapid, and bilateral delayed staging deep brain stimulation for Parkinson’s disease9
Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms9
Structural Connectivity of Subthalamic Nucleus Stimulation for Improving Freezing of Gait9
Neural Oscillations and Functional Significances for Prioritizing Dual-Task Walking in Parkinson’s Disease9
Fear of Progression is Determined by Anxiety and Self-Efficacy but not Disease-Specific Parameters in Patients with Parkinson’s Disease: Preliminary Data from a Multicenter Cross-Sectional Study9
PARKinSOUND: Impact of participation in an orchestra in patients with Parkinson's disease9
Parkinson's disease participant-led research on the impact of deep brain stimulation frequency9
Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials9
Lactobacillaceae and Parkinson's disease: An apparent paradox9
Association Between Menopausal Hormone Therapy and Risk for Parkinson’s Disease9
Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s Disease9
Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder9
Addressing the “Replication Crisis” in the Field of Parkinson’s Disease9
Colonoscopy and Subsequent Risk of Parkinson’s Disease9
Reaching and Grasping Movements in Parkinson’s Disease: A Review9
Factors Associated with Preferred Place of Care and Death in Patients with Parkinson’s Disease: A Cross-Sectional Study9
Diverse preferences, different solutions: Exploring remote monitoring preferences in Parkinson's disease through a discrete choice experiment9
Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic9
Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder8
Clinical Trial Highlights – Interventions Promoting Physical Activity in Parkinson’s Disease8
Evaluation of the Impact of Integrated Care and Self-Management After Deep Brain Stimulation in Parkinson’s Disease8
A Randomized, Double-Blinded Crossover Trial of Short Versus Conventional Pulse Width Subthalamic Deep Brain Stimulation in Parkinson’s Disease8
The Role of Monoaminergic Tones and Brain Metabolism in Cognition in De Novo Parkinson’s Disease8
An Evaluation of KELVIN, an Artificial Intelligence Platform, as an Objective Assessment of the MDS UPDRS Part III8
Cognitive Effects of Three β-Adrenoceptor Acting Drugs in Healthy Volunteers and Patients with Parkinson’s Disease8
Evaluation of Bedside Tests of Attention and Arousal Assessing Delirium in Parkinson’s Disease, Dementia, and Older Adults8
mHealth-assisted expiratory muscle strength training in Parkinson's disease patients: A proof-of-concept study8
Premorbid Educational Attainment and Long-Term Motor Prognosis in Parkinson’s Disease8
Declining trends in the incidence of Parkinson's disease: A cohort study in Germany8
Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson’s Disease8
Neuropsychiatric Symptoms and Caregiver Stress in Parkinson’s Disease with Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia8
Video-Based Automated Assessment of Movement Parameters Consistent with MDS-UPDRS III in Parkinson’s Disease8
Visualization of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale Results8
Ankylosing Spondylitis: A Risk Factor for Parkinsonism—A Nationwide Population-Based Study8
The Effect of a Structured Medication Review on Quality of Life in Parkinson’s Disease8
Chronotropic Incompetence During Exercise Testing as a Marker of Autonomic Dysfunction in Individuals with Early Parkinson’s Disease8
Immunogenetic Determinants of Parkinson’s Disease Etiology8
Sleep Disorders in Early-Onset Parkinsonism: A Population-Based Study8
Reading Difficulties in Parkinson’s Disease: A Stepped Care Model for Neurovisual Rehabilitation8
Stochastic Epigenetic Mutations Influence Parkinson’s Disease Risk, Progression, and Mortality8
The proSAAS Chaperone Provides Neuroprotection and Attenuates Transsynaptic α-Synuclein Spread in Rodent Models of Parkinson’s Disease8
The Etiology of Parkinson’s Disease: New Perspectives from Gene-Environment Interactions8
Hidden Gems in the Neurological Literature of Progressive Supranuclear Palsy8
Tackling gender in progressive supranuclear palsy: Male patients present more apathy8
Gaps in the Parkinson's disease therapeutic clinical pipeline: A focus on approaches targeting disease pathobiology8
The Impact of Motor, Non-Motor, and Social Aspects on the Sexual Health of Men Living with Parkinson’s Disease8
Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease7
Advice to people with Parkinson's in my clinic: Get a cardiopulmonary exercise test7
Self-delivered arousal-heightening stimuli to improve mobility in persons with parkinsonism: A case series7
Fear of progression in Parkinson's disease: Role of age and occupational status7
Risk Factors for Postoperative Delirium Severity After Deep Brain Stimulation Surgery in Parkinson’s Disease7
Which Gait Tasks Produce Reliable Outcome Measures of Freezing of Gait in Parkinson’s Disease?7
Alcohol and Parkinson’s Disease: A Systematic Review and Meta-Analysis7
Pathophysiology and pharmacological management for sleep problems in Parkinson's disease7
The Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease on Associative Learning of Verbal and Non-Verbal Information by Trial and Error or with Corrective Feedback7
Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson’s Disease7
“No One Can Tell Me How Parkinson’s Disease Will Unfold”: A Mixed Methods Case Study on Palliative Care for People with Parkinson’s Disease and Their Family Caregivers7
Dopamine-responsive post-anoxic parkinsonism7
Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease7
Pain and the Non-Pharmacological Management of Pain in People with Parkinson’s Disease7
The Importance of Digital Health Literacy in an Evolving Parkinson’s Disease Care System7
Digital Intervention Promoting Physical Activity in People Newly Diagnosed with Parkinson’s Disease: Feasibility and Acceptability of the Knowledge, Exercise-Efficacy and Participation (KEEP) Interven7
Pilot Study Results Assessing the Accuracy of a Ballistic Sleep Monitor Relative to Polysomnography in Parkinson’s Disease7
Association Between Parkinson’s Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis7
Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop7
A perspective of persons with Parkinson's disease on the contribution of alpha-synuclein seed amplification assay biomarker to the diagnosis of Parkinson's disease7
Visual hallucinations in Parkinson's disease are associated with deficits in social perception7
Considerations on How to Prevent Parkinson’s Disease Through Exercise7
Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study7
Apathy linked to higher amyloid burden and cognitive deterioration in Parkinson's disease7
Recognition, management, and patient perspectives of impulsive-compulsive disorders in Parkinson’s disease7
New Journal Section: Hidden Gems from the Literature of Parkinson’s Disease7
The future of clinical trials? Monitoring mobility as an outcome measure in Parkinson's disease: The mobilise-D study6
Shades of grey: The continuum of therapies for Parkinson's disease along the spectrum of credibility6
0.38569808006287